These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 15269523)

  • 1. High-level production of soluble tumor necrosis factor-related apoptosis-inducing ligand (Apo2L/TRAIL) in high-density cultivation of recombinant Escherichia coli using a combined feeding strategy.
    Shen YL; Zhang Y; Sun AY; Xia XX; Wei DZ; Yang SL
    Biotechnol Lett; 2004 Jun; 26(12):981-4. PubMed ID: 15269523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Refolding and purification of Apo2l/TRAIL produced as inclusion bodies in high-cell-density cultures of recombinant Escherichia coli.
    Shen YL; Xia XX; Zhang Y; Liu JW; Wei DZ; Yang SL
    Biotechnol Lett; 2003 Dec; 25(24):2097-101. PubMed ID: 14969416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization of culture on the overproduction of TRAIL in high-cell-density culture by recombinant Escherichia coli.
    Luo Q; Shen YL; Wei DZ; Cao W
    Appl Microbiol Biotechnol; 2006 Jun; 71(2):184-91. PubMed ID: 16215715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [High-cell density cultivation of recombinant Escherichia coli for production of TRAIL by using a 2-stage feeding strategy].
    Zhang Y; Shen YL; Xia XX; Sun AY; Wei DZ; Zhou JS; Zhang GJ; Wang LH; Jiao BH
    Sheng Wu Gong Cheng Xue Bao; 2004 May; 20(3):408-13. PubMed ID: 15971615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression, purification and crystallization of recombinant human TRAIL.
    Cha SS; Shin HC; Choi KY; Oh BH
    Acta Crystallogr D Biol Crystallogr; 1999 May; 55(Pt 5):1101-4. PubMed ID: 10216319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of expression level and bioactivity of soluble tumor necrosis factor-related apoptosis-inducing ligand (Apo2L/TRAIL) by a novel zinc ion feeding strategy.
    Sun AY; Shen YL; Yin JC; Zhang H; Tang YN; Wei DZ
    Biotechnol Lett; 2006 Aug; 28(15):1215-9. PubMed ID: 16799759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenoviral (full-length) Apo2L/TRAIL gene transfer is an ineffective treatment strategy for malignant glioma.
    Naumann U; Waltereit R; Schulz JB; Weller M
    J Neurooncol; 2003 Jan; 61(1):7-15. PubMed ID: 12587790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of expressed TRAIL on biophysical properties of the human leukemic cell line Jurkat.
    Chen K; Li D; Jiang YH; Yao WJ; Wang XJ; Wei XC; Gao J; Xie LD; Yan ZY; Wen ZY; Chien S
    Cell Res; 2004 Apr; 14(2):161-8. PubMed ID: 15115618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-human hepatocellular carcinoma effects of tumor necrosis factor-related apoptosis-inducing ligand in vitro & in vivo.
    Guo BC; Xu YH
    Acta Pharmacol Sin; 2001 Sep; 22(9):831-6. PubMed ID: 11749866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct stimulation of apoptotic signaling by soluble Apo2l/tumor necrosis factor-related apoptosis-inducing ligand leads to selective killing of glioma cells.
    Pollack IF; Erff M; Ashkenazi A
    Clin Cancer Res; 2001 May; 7(5):1362-9. PubMed ID: 11350907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of recombinant TRAIL and TRAIL receptor: Fc chimeric proteins.
    Schneider P
    Methods Enzymol; 2000; 322():325-45. PubMed ID: 10914028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Induction of apoptosis in various cancer cell lines by human soluble TRAIL expressed in Escherichia coli].
    Zheng X; Guan X; Lin Z
    Zhonghua Yi Xue Za Zhi; 2000 Mar; 80(3):190-2. PubMed ID: 11798756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in established and primary glioma cell lines.
    Jaganathan J; Petit JH; Lazio BE; Singh SK; Chin LS
    Neurosurg Focus; 2002 Sep; 13(3):ecp1. PubMed ID: 15844877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced proliferation and increased IFN-gamma production in T cells by signal transduced through TNF-related apoptosis-inducing ligand.
    Chou AH; Tsai HF; Lin LL; Hsieh SL; Hsu PI; Hsu PN
    J Immunol; 2001 Aug; 167(3):1347-52. PubMed ID: 11466352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective leakage of host-cell proteins during high-cell-density cultivation of recombinant and non-recombinant Escherichia coli.
    Rinas U; Hoffmann F
    Biotechnol Prog; 2004; 20(3):679-87. PubMed ID: 15176868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fed-batch production of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in soluble form in Escherichia coli and its purification and characterization.
    Li P; Gu Q; Wu X
    Protein Expr Purif; 2016 Oct; 126():115-121. PubMed ID: 27335160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand cooperates with chemotherapy to inhibit orthotopic lung tumor growth and improve survival.
    Jin H; Yang R; Fong S; Totpal K; Lawrence D; Zheng Z; Ross J; Koeppen H; Schwall R; Ashkenazi A
    Cancer Res; 2004 Jul; 64(14):4900-5. PubMed ID: 15256461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Over-expression of recombinant human interferon-gamma in high cell density fermentation of Escherichia coli.
    Khalilzadeh R; Shojaosadati SA; Bahrami A; Maghsoudi N
    Biotechnol Lett; 2003 Dec; 25(23):1989-92. PubMed ID: 14719811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging non-apoptotic functions of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/Apo2L.
    Di Pietro R; Zauli G
    J Cell Physiol; 2004 Dec; 201(3):331-40. PubMed ID: 15389537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heat-induced production of human growth hormone by high cell density cultivation of recombinant Escherichia coli.
    Tabandeh F; Shojaosadati SA; Zomorodipour A; Khodabandeh M; Sanati MH; Yakhchali B
    Biotechnol Lett; 2004 Feb; 26(3):245-50. PubMed ID: 15049371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.